½ÃÀ庸°í¼­
»óǰÄÚµå
1594493

Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : Á¦Ç°º°, ¿öÅ©Ç÷ο캰 - ¼¼°è ¿¹Ãø(2025-2030³â)

Next-Generation Sequencing Data Analysis Market by Product (Analytical Software, NGS Commercial Software, Platform OS/UI), Workflow (Calling, Detections, Primary) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀº 2023³â¿¡ 3¾ï 767¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 3¾ï 4,385¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 11.85%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 6¾ï 7,387¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Â÷¼¼´ë ½ÃÄö½Ì(NGS) µ¥ÀÌÅÍ ºÐ¼®Àº DNA¿Í RNAÀÇ ½Å¼ÓÇÑ ½ÃÄö½ÌÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á À¯Àüü ¿¬±¸¸¦ Çõ½ÅÇÏ°í ¸ÂÃãÇü ÀÇ·á, ¾Ï ¿¬±¸ ¹× À¯ÀüÀû ÁúȯÀÇ ½Äº°À» ÃËÁøÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¹æ´ëÇÑ ¾çÀÇ À¯Àüü µ¥ÀÌÅ͸¦ È¿À²ÀûÀ¸·Î ó¸®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î Á¤ÀǵǴ NGS µ¥ÀÌÅÍ ºÐ¼®Àº ǰÁú°ü¸®, ¼­¿­ Á¤·Ä, º¯ÀÌü ½Äº° µî ¿©·¯ ´Ü°è¸¦ Æ÷ÇÔÇϸç, NGS µ¥ÀÌÅÍ ºÐ¼®ÀÇ Çʿ伺Àº Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¾ÇÕÀûÀÎ À¯Àüü ÇÁ·ÎÆÄÀϸµÀÇ Çʿ伺 Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Çʿ伺ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÓ»ó Áø´Ü, ÀǾàǰ °³¹ß, ³ó¾÷, °¨¿°º´ ¿¬±¸ µî¿¡ Å« ÀÀ¿ëÀÌ ±â´ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀڷδ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ, ¿¬±¸ ±â°ü, »ý¸í°øÇÐ ±â¾÷, ³ó¾÷ ±â¾÷ µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½ÃÄö½Ì ±â¼úÀÇ ±â¼úÀû Áøº¸, ºñ¿ë Àý°¨, À¯ÀüÀÚ °Ë»çÀÇ º¸±Þ·ü Çâ»óÀÔ´Ï´Ù. ¶ÇÇÑ À¯Àüü ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎÀÇ °­·ÂÇÑ Áö¿ø°ú ÅõÀÚ, Áø´Ü ºÐ¾ß¿¡¼­ NGSÀÇ Ã¤Åà Áõ°¡µµ Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¸ÞŸÀ¯Àüü ¹× ÈļºÀ¯ÀüüÇÐ(metagenomics), ÈļºÀ¯ÀüüÇÐ(epigenomics)°ú °°Àº ¿ëµµ°¡ È®´ëµÇ°í, µ¥ÀÌÅÍ ºÐ¼®¿¡ ´ëÇÑ Á¢±ÙÀ» ¹ÎÁÖÈ­ÇÒ ¼ö Àִ Ŭ¶ó¿ìµå ±â¹Ý ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¼Ö·ç¼Çµµ ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺, Ç¥ÁØÈ­ ¹®Á¦, À¯Àüü µ¥ÀÌÅÍ¿¡ ´ëÇÑ ÇÁ¶óÀ̹ö½Ã ¹®Á¦ µîÀÌ °úÁ¦·Î ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼÷·ÃµÈ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º Àü¹®°¡ ºÎÁ·ÀÌ Å« À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. À̸¦ ÇØ°áÇϱâ À§ÇØ Çõ½ÅÀº Ç¥ÁØÈ­ ¹× µ¥ÀÌÅÍ °øÀ¯ °üÇàÀ» °­È­Çϱâ À§ÇØ ÀÌÇØ °ü°èÀÚ°£ÀÇ Çù·ÂÀ» ÃËÁøÇÏ´Â µ¿½Ã¿¡ »ç¿ëÀÚ Ä£È­ÀûÀÎ »ý¹° Á¤º¸ÇÐ Åø¿Í °­·ÂÇÑ µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛÀ» °³¹ßÇÏ´Â µ¥ ÁßÁ¡À» µÎ¾î¾ßÇÕ´Ï´Ù. ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú °æÀï ¾Ð·ÂÀ¸·Î ÀÎÇØ ¿ªµ¿ÀûÀΠƯ¼ºÀ» º¸¿©Áֱ⠶§¹®¿¡ Áö¼ÓÀûÀÎ ÀûÀÀ°ú Àü·«Àû ¼±°ßÁö¸íÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óȲÀ» ¼º°øÀûÀ¸·Î ±Øº¹Çϱâ À§Çؼ­´Â R&D¿¡ ´ëÇÑ Àû±ØÀûÀÎ ÅõÀÚ, ±ÔÁ¦ »óȲ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Áö½Ä, ±âÁ¸ ÇѰ踦 ±Øº¹ÇÏ°í »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇÑ Çù·ÂÀû ÇÁ·¹ÀÓ¿öÅ©ÀÇ ½ÇÇàÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 3¾ï 767¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 3¾ï 4,385¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 6¾ï 7,387¸¸ ´Þ·¯
CAGR(%) 11.85%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÄö¼­¿¡¼­ »ý¼ºµÇ´Â ´ë·®ÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®Çϱâ À§ÇÑ ¾Ë°í¸®Áò°ú Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ¾Ï µ¹¿¬º¯ÀÌ ½Äº°¿¡ ÀÖÀ¸¸ç, NGS ºÐ¼®ÀÇ ÀáÀçÀû Á߿伺
    • Á¤¹ÐÀÇ·á ¹× ºÐÀÚÁø´Ü¿¡¼­ÀÇ NGS ±â¼ú Ȱ¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • NGS Ç÷§ÆûÀÇ º¹ÀâÇÑ µ¥ÀÌÅ͸¦ ÇØ¼®ÇÏ´Â ¹æ¹ý
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú µ¥ÀÌÅÍ ÅëÇÕÀÇ ±â¼úÀû Áøº¸
    • NGS µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ºòµ¥ÀÌÅÍÀÇ µîÀå
  • ½ÃÀå °úÁ¦
    • NGS µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces: Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû Æ÷Áö¼Å´×À» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå¿¡¼­ÀÇ º¥´õº° ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

Â÷¼¼´ë ½ÃÄö¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ±â¾÷Àº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : Á¦Ç°º°

  • ¼­·Ð
  • ÇØ¼® ¼ÒÇÁÆ®¿þ¾î
  • NGS »ó¿ë ¼ÒÇÁÆ®¿þ¾î
  • Ç÷§Æû OS/UI
  • ¼­ºñ½º

Á¦7Àå Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå : ¿öÅ©Ç÷ο캰

  • ¼­·Ð
  • È£Ãâ
  • ŽÁö
  • 1Â÷
  • ÁöµµÁ¦ÀÛ µ¶ÀÔ
  • 2Â÷
  • 3Â÷

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Â÷¼¼´ë ½ÃÄý¼­ µ¥ÀÌÅÍ ºÐ¼® ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ÇØ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ÇØ¼®
  • Àü·« ÇØ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Computomics GmbH
  • DNAnexus, Inc.
  • DNASTAR, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics, Inc.
  • Genomatix GmbH
  • Golden Helix, Inc.
  • Illumina, Inc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • Partek, Inc.
  • PierianDx, Inc.
  • Thermo Fisher Scientific, Inc.
KSA 24.11.29

The Next-Generation Sequencing Data Analysis Market was valued at USD 307.67 million in 2023, expected to reach USD 343.85 million in 2024, and is projected to grow at a CAGR of 11.85%, to USD 673.87 million by 2030.

Next-Generation Sequencing (NGS) Data Analysis is pivotal in transforming genomic studies by enabling rapid sequencing of DNA and RNA, thus fostering personalized medicine, cancer research, and genetic disorder identification. Defined by its ability to process vast genomic data efficiently, NGS data analysis involves several steps such as quality control, sequence alignment, and variant identification. The necessity of NGS data analysis stems from growing demands in precision medicine and an increasing need for comprehensive genomic profiling. It finds significant applications in clinical diagnostics, pharmaceutical development, agriculture, and infectious disease research. Key end-users include healthcare providers, research institutions, biotechnology firms, and agricultural enterprises. Market growth is fueled by technological advancements in sequencing technologies, decreasing costs, and increasing prevalence of genetic testing. Moreover, strong governmental support and investment in genomic research, as well as rising adoption of NGS in diagnostics, are critical growth drivers. Opportunities exist in expanding application areas such as metagenomics and epigenomics, along with cloud-based bioinformatics solutions that promise to democratize data analysis accessibility. However, challenges include data interpretation complexity, standardization issues, and privacy concerns related to genomic data. Additionally, a shortage of skilled bioinformatics professionals poses a significant barrier. To address these, innovation should focus on developing user-friendly bioinformatics tools and robust data management systems, alongside fostering collaborations among stakeholders to enhance standardization and data sharing practices. The market displays a dynamic nature, driven by rapid technological advancements and competitive pressures, thus requiring continuous adaptation and strategic foresight. Successful navigation of this landscape demands proactive investment in research and development, comprehensive knowledge of regulatory requirements, and execution of collaborative frameworks aimed at addressing existing limitations and leveraging emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 307.67 million
Estimated Year [2024] USD 343.85 million
Forecast Year [2030] USD 673.87 million
CAGR (%) 11.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation Sequencing Data Analysis Market

The Next-Generation Sequencing Data Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for algorithms and tools for analysis of a large amount of data generated by sequencers
    • Potential significance of NGS analysis in identifying cancer mutations
    • Application of NGS technology in precision medicine and molecular diagnostics
  • Market Restraints
    • Interpretation of complex data from NGS platforms
    • Lack of skilled professionals
  • Market Opportunities
    • Technological advancements in cloud computing and data integration
    • Emergence of the big data for analyzing NGS Data
  • Market Challenges
    • Security and privacy of concerns for NGS Data

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation Sequencing Data Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation Sequencing Data Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation Sequencing Data Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation Sequencing Data Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation Sequencing Data Analysis Market

A detailed market share analysis in the Next-Generation Sequencing Data Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation Sequencing Data Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation Sequencing Data Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation Sequencing Data Analysis Market

A strategic analysis of the Next-Generation Sequencing Data Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Sequencing Data Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Computomics GmbH, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fabric Genomics, Inc., Genomatix GmbH, Golden Helix, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., Partek Incorporated, Partek, Inc., PierianDx, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Sequencing Data Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analytical Software, NGS Commercial Software, Platform OS/UI, and Services.
  • Based on Workflow, market is studied across Calling, Detections, Primary, Read Mapping, Secondary, and Tertiary.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for algorithms and tools for analysis of a large amount of data generated by sequencers
      • 5.1.1.2. Potential significance of NGS analysis in identifying cancer mutations
      • 5.1.1.3. Application of NGS technology in precision medicine and molecular diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Interpretation of complex data from NGS platforms
      • 5.1.2.2. Lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cloud computing and data integration
      • 5.1.3.2. Emergence of the big data for analyzing NGS Data
    • 5.1.4. Challenges
      • 5.1.4.1. Security and privacy of concerns for NGS Data
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next-Generation Sequencing Data Analysis Market, by Product

  • 6.1. Introduction
  • 6.2. Analytical Software
  • 6.3. NGS Commercial Software
  • 6.4. Platform OS/UI
  • 6.5. Services

7. Next-Generation Sequencing Data Analysis Market, by Workflow

  • 7.1. Introduction
  • 7.2. Calling
  • 7.3. Detections
  • 7.4. Primary
  • 7.5. Read Mapping
  • 7.6. Secondary
  • 7.7. Tertiary

8. Americas Next-Generation Sequencing Data Analysis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Next-Generation Sequencing Data Analysis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Next-Generation Sequencing Data Analysis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Computomics GmbH
  • 4. DNAnexus, Inc.
  • 5. DNASTAR, Inc.
  • 6. Eurofins Scientific SE
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Fabric Genomics, Inc.
  • 9. Genomatix GmbH
  • 10. Golden Helix, Inc.
  • 11. Illumina, Inc.
  • 12. Pacific Biosciences of California, Inc.
  • 13. Partek Incorporated
  • 14. Partek, Inc.
  • 15. PierianDx, Inc.
  • 16. Thermo Fisher Scientific, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦